Sandbox leucocytosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 772: | Line 772: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pregnancy | * Pregnancy | ||
| | | | ||
Line 781: | Line 781: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Medication | * Medication | ||
| | | | ||
Line 790: | Line 790: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Smoker's melanosis | * Smoker's melanosis | ||
| | | | ||
Line 801: | Line 801: | ||
| rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Vesicular/Ulcerative/Erythematous | * Vesicular/Ulcerative/Erythematous | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hereditary | * Hereditary | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epidermolysis bullosa | * Epidermolysis bullosa | ||
| | | | ||
Line 812: | Line 812: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="6" | | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Viral | * Viral | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpes simplex | * Herpes simplex | ||
| | | | ||
Line 823: | Line 823: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpangina | * Herpangina | ||
| | | | ||
Line 832: | Line 832: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hand foot and mouth disease | * Hand foot and mouth disease | ||
| | | | ||
Line 841: | Line 841: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Herpes zoster | * Herpes zoster | ||
| | | | ||
Line 850: | Line 850: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Infectious mononucleosis | * Infectious mononucleosis | ||
| | | | ||
Line 859: | Line 859: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Varicella | * Varicella | ||
| | | | ||
Line 868: | Line 868: | ||
| | | | ||
|- | |- | ||
| rowspan="5" | | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Autoimmune | * Autoimmune | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erosive lichen planus | * Erosive lichen planus | ||
| | | | ||
Line 879: | Line 879: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mucous memrane pemphigoid | * Mucous memrane pemphigoid | ||
| | | | ||
Line 888: | Line 888: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pemphigous vulgaris | * Pemphigous vulgaris | ||
| | | | ||
Line 897: | Line 897: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Bullous pemphigoid | * Bullous pemphigoid | ||
| | | | ||
Line 906: | Line 906: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lupus erythmatosus | * Lupus erythmatosus | ||
| | | | ||
Line 915: | Line 915: | ||
| | | | ||
|- | |- | ||
| rowspan="5" | | | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Idiopathic | * Idiopathic | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Aphthous ulcer | * Aphthous ulcer | ||
| | | | ||
Line 926: | Line 926: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erythema multiforme | * Erythema multiforme | ||
| | | | ||
Line 935: | Line 935: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Erythroplakia | * Erythroplakia | ||
| | | | ||
Line 944: | Line 944: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Medication induced mucositis | * Medication induced mucositis | ||
| | | | ||
Line 953: | Line 953: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Contact stomatitis | * Contact stomatitis | ||
| | | | ||
Line 962: | Line 962: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mycotic | * Mycotic | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Candidiosis | * Candidiosis | ||
| | | | ||
Line 982: | Line 982: | ||
| rowspan="38" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="38" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Tumor/Neoplasms | * Tumor/Neoplasms | ||
| rowspan="24" |Benign | | rowspan="24" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
| rowspan="3" |Epithelial | * Benign | ||
| | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epithelial | |||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | |||
* Papilloma | * Papilloma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 992: | Line 994: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Verruca vulgaris | * Verruca vulgaris | ||
| | | | ||
Line 1,000: | Line 1,002: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Condyloma acuminatum | * Condyloma acuminatum | ||
| | | | ||
Line 1,008: | Line 1,010: | ||
| | | | ||
|- | |- | ||
| rowspan="14" |Mesenchymal | | rowspan="14" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
| | * Mesenchymal | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | |||
* Fibroma | * Fibroma | ||
| | | | ||
Line 1,017: | Line 1,020: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peripheral ossifying fibroma | * Peripheral ossifying fibroma | ||
| | | | ||
Line 1,025: | Line 1,028: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Leiomyoma | * Leiomyoma | ||
| | | | ||
Line 1,033: | Line 1,036: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Rhabdomyoma | * Rhabdomyoma | ||
| | | | ||
Line 1,041: | Line 1,044: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peripheral giant cell granuloma | * Peripheral giant cell granuloma | ||
| | | | ||
Line 1,049: | Line 1,052: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hemangioma | * Hemangioma | ||
| | | | ||
Line 1,057: | Line 1,060: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lymphangioma | * Lymphangioma | ||
| | | | ||
Line 1,065: | Line 1,068: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pyogenic granuloma | * Pyogenic granuloma | ||
| | | | ||
Line 1,073: | Line 1,076: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lipoma | * Lipoma | ||
| | | | ||
Line 1,081: | Line 1,084: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Neuroma | * Neuroma | ||
| | | | ||
Line 1,089: | Line 1,092: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Neurofibroma | * Neurofibroma | ||
| | | | ||
Line 1,097: | Line 1,100: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Schwannoma | * Schwannoma | ||
| | | | ||
Line 1,105: | Line 1,108: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Granular cell tumor | * Granular cell tumor | ||
| | | | ||
Line 1,113: | Line 1,116: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Congenital epulis | * Congenital epulis | ||
| | | | ||
Line 1,121: | Line 1,124: | ||
| | | | ||
|- | |- | ||
| rowspan="7" |Salivary gland | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
| | * Salivary gland | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | |||
* Pleomorphic adenoma | * Pleomorphic adenoma | ||
| | | | ||
Line 1,130: | Line 1,134: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Papillary cystadenoma lymphomatosum | * Papillary cystadenoma lymphomatosum | ||
| | | | ||
Line 1,138: | Line 1,142: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Adenoid cystic carcinoma | * Adenoid cystic carcinoma | ||
| | | | ||
Line 1,146: | Line 1,150: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Acinic cell adenocarcinoma | * Acinic cell adenocarcinoma | ||
| | | | ||
Line 1,154: | Line 1,158: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Mucoepidermoid carcinoma low grade | * Mucoepidermoid carcinoma low grade | ||
| | | | ||
Line 1,162: | Line 1,166: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Polymorphous low grade adenocarcinoma | * Polymorphous low grade adenocarcinoma | ||
| | | | ||
Line 1,170: | Line 1,174: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Acinic cell adenocarcinoma | * Acinic cell adenocarcinoma | ||
| | | | ||
Line 1,178: | Line 1,182: | ||
| | | | ||
|- | |- | ||
| rowspan="4" |Cyst | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
| | * Cyst | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | |||
* Gingival cyst of adult | * Gingival cyst of adult | ||
| | | | ||
Line 1,188: | Line 1,193: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lymphoepithelial cyst | * Lymphoepithelial cyst | ||
| | | | ||
Line 1,197: | Line 1,202: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epidermoid/dermoid cyst | * Epidermoid/dermoid cyst | ||
| | | | ||
Line 1,206: | Line 1,211: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Thyroglossal tract cyst | * Thyroglossal tract cyst | ||
| | | | ||
Line 1,215: | Line 1,220: | ||
| | | | ||
|- | |- | ||
| rowspan="10" |Malignant | | rowspan="10" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
| | * Malignant | ||
| style="background: #DCDCDC; padding: 5px; text-align: left;" | | |||
* Squamous cell carcinoma | * Squamous cell carcinoma | ||
| | | |
Revision as of 06:53, 24 January 2019
Disease | Presentation | Risk Factors | Diagnosis | Affected Organ Systems | Important features | Picture |
---|---|---|---|---|---|---|
Diseases predominantly affecting the oral cavity | ||||||
Oral Candidiasis |
|
|
|
Localized candidiasis
Invasive candidasis |
|
|
Herpes simplex oral lesions |
|
|
|
|
||
Aphthous ulcers |
|
|
|
|
|
|
Squamous cell carcinoma |
|
|
||||
Leukoplakia |
|
|
|
|
||
Melanoma |
|
|
|
|
||
Fordyce spots |
|
|
|
|
||
Burning mouth syndrome |
|
|
||||
Torus palatinus |
|
|||||
Diseases involving oral cavity and other organ systems | ||||||
Behcet's disease |
|
|
|
|||
Crohn's disease |
|
|
|
|||
Agranulocytosis |
|
|
||||
Syphilis |
|
|
|
|||
Coxsackie virus |
|
|
||||
Chicken pox |
|
|
|
|
||
Measles |
|
|
|
|
Surface Lesions of Oral Mucosa | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
|
|
|
|||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
Soft Tissue Lesion | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||
|
|
|
|
|||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Type of cancer | Subtype | Epidemiology | Localization | Clinical features | Diagnostic procedures |
---|---|---|---|---|---|
Squamous cell carcinoma
|
Verrucous carcinoma |
|
|
|
Biopsy shows:
Thickened club-shaped papillae and blunt stromal invaginations of well-differentiated squamous epithelium with marked keratinization |
Lymphoepithelial carcinoma | 0.8-2% of all oral or oropharyngeal cancers |
|
|
Biopsy chows:
| |
Epithelial precursor lesions | --- | --- | Seen in the entire digestive tract |
|
Biopsy shows:
|
Proliferative verrucous leukoplakia and precancerous conditions | --- |
|
|
An aggressive form of oral leukoplakia with considerable morbidity and
strong predilection to malignant transformation |
Biopsy shows:
|
Papillomas | Squamous cell papilloma and |
|
Any oral site may be affected mostly:
|
Soft, pedunculated lesions formed by a cluster of finger-like fronds or a sessile, dome-shaped lesion with a nodular, papillary or verrucous surface | Biopsy shows:
|
Condyloma acuminatum | 2nd and 5th decade with a peak in teenagers and young adults |
|
Biopsy shows:
Several sessile, cauliflower-like swellings forming a cluster | ||
Focal epithelial hyperplasia | Disease of children, adolescents and young adults |
|
|
Biopsy shows:
| |
Granular cell tumor | --- |
|
|
|
Biopsy shows:
|
Keratoacanthoma | --- |
whites
men as in women |
|
|
Biopsy shows:
|
Papillary hyperplasia | --- | Affects all age groups | Palate | Asymptomatic nodular or papillary mucosal lesion | Biopsy shows:
|
Median rhomboid glossitis | --- | --- | Dorsum of the tongue at the junction of the anterior two thirds
and posterior third |
Forms a patch of papillary atrophy in the region of the
embryological foramen caecum |
Biopsy shows:
|
Salivary gland tumors | Acinic cell carcinoma |
|
Tumors usually
form non-descript swellings |
Biopsy shows:
| |
Mucoepidermoid carcinoma |
|
|
|
Low power microscopy shows low-grade tumor with both cystic and solid areas and an inflamed, fibrous stroma | |
Adenoid cystic carcinoma |
|
|
Predominantly solid variant shows peri- and intraneural invasion | ||
Epithelial-myoepithelial
carcinoma |
--- | --- | --- | --- | |
Clear cell carcinoma,
NOS |
--- | --- | --- | ||
Basal cell | Rare in minor glands | Asymptomatic, smooth or lobulated sub-mucosal masses | Microscopically similar to basal
cell adenocarcinomas of the major gland | ||
Cystadenocarcinoma | 32% developed in the minor glands |
|
Slow growing and painless but
some palatal tumors may erode the underlying bone causing sinonasal complex |
--- | |
Salivary duct carcinoma |
|
|
Tumors formed painless swellings but many in the palate can be painful and ulcerated or fungated with metastases to regional lymph nodes | The range of
microscopical appearances is similar to that seen in the major glands | |
Salivary gland adenomas | Pleomorphic adenoma | 40-70% of minor gland tumors |
|
Painless, slow growing, submucosal masses, but when | Biopsy shows cellular, and hyaline or plasmacytoid cell |
Myoepithelioma | 42% of minor gland tumors |
|
--- | --- | |
Basal cell adenoma | 20% of minor gland tumors | --- | They are histologically
similar to those in major glands. | ||
Cystadenoma | 7% of benign minor gland tumors | --- | --- | ||
Kaposi sarcoma | --- |
|
|
Biopsy of all 4 types show:
| |
Lymphangioma | --- |
|
Tongue |
|
Biopsy shows:
|
Ectomesenchymal chondromyxoid
tumour of the anterior tongue |
--- |
|
--- | Asymptomatic, slow growing solitary nodule in the anterior dorsal tongue | Biopsy shows:
|
Focal oral mucinosis (FOM) | --- |
|
Asymptomatic fibrous or cystic-like lesion | Histopathology is characterized by:
| |
Congenital granular cell epuli | --- |
|
Solitary, somewhat pedunculated fibroma-like lesion attached to the alveolar
ridge near the midline |
||
Hematolymphoid tumors | Non-Hodgkin lymphoma | Second most common cancer of the oral cavity |
|
NHL of the lip presents with:
|
Biopsy shows:
|
Langerhans cell histiocytosis | --- |
and |
Common oral symptoms
include:
|
Biopsy shows ovoid Langerhans cells
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |
Hodgkin lymphoma | --- |
|
Most patients present with localized disease (stage I/II), with
|
--- | |
Extramedullary myeloid
sarcoma |
--- | Isolated tumor-forming intraoral mass | Biopsy shows an Indian-file pattern of infiltration | ||
Follicular dendritic cell
sarcoma / tumour |
|
|
The patients usually
present with a painless mass |
Biopsy usually exhibits
borders and comprises:
| |
Mucosal malignant melanoma | --- |
|
80% arise:
Others:
|
|
|